SUCCESSFUL TREATMENT OF INVASIVE ASPERGILLOSIS COMPLICATING PROLONGED TREATMENT-RELATED NEUTROPENIA IN ACUTE MYELOGENOUS LEUKEMIA WITH AMPHOTERICIN-B LIPID COMPLEX

被引:22
作者
HOSPENTHAL, DR [1 ]
BYRD, JC [1 ]
WEISS, RB [1 ]
机构
[1] WALTER REED ARMY MED CTR,DEPT MED,HEMATOL ONCOL SERV,WASHINGTON,DC 20307
来源
MEDICAL AND PEDIATRIC ONCOLOGY | 1995年 / 25卷 / 02期
关键词
ASPERGILLOSIS; LIPOSOME; AMPHOTERICIN B; LEUKEMIA; NEUTROPENIA;
D O I
10.1002/mpo.2950250214
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Herein we report the successful treatment of invasive aspergillosis with the liposomal amphotericin B (AMB) formulation, Amphotericin and Lipid Complex (ABLC(TM)). This investigational compound was employed in a 50-year-old patient with acute myelomonocytic leukemia complicated by prolonged, treatment-induced granulocytopenia and documented Aspergillus flavus sinusitis with signs of disseminated aspergillosis. The patient demonstrated radiographic signs of pulmonary aspergillosis and biochemical signs of hepatic involvement that were resistant to a 23 day course of conventional AMB (Fungizone(R)) therapy. Following therapy with ABLC(TM) her fever abated, her chest X-ray findings improved, and her hepatic function tests improved with eventual resolution. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:119 / 122
页数:4
相关论文
共 18 条
[1]  
ALLENDOERFER R, 1992, J MED VET MYCOL, V30, P377
[2]   FAVORABLE OUTCOME OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH ACUTE-LEUKEMIA [J].
BURCH, PA ;
KARP, JE ;
MERZ, WG ;
KUHLMAN, JE ;
FISHMAN, EK .
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (12) :1985-1993
[3]  
BYRD JC, 1993, BLOOD S1, V82, P138
[4]   AMPHOTERICIN-B LIPID COMPLEX THERAPY OF EXPERIMENTAL FUNGAL-INFECTIONS IN MICE [J].
CLARK, JM ;
WHITNEY, RR ;
OLSEN, SJ ;
GEORGE, RJ ;
SWERDEL, MR ;
KUNSELMAN, L ;
BONNER, DP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (04) :615-621
[5]   COMPARATIVE EFFICACIES OF AMPHOTERICIN-B LIPID COMPLEX AND AMPHOTERICIN-B DEOXYCHOLATE SUSPENSION AGAINST MURINE BLASTOMYCOSIS [J].
CLEMONS, KV ;
STEVENS, DA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (10) :2144-2146
[6]  
DENNING DW, 1990, REV INFECT DIS, V12, P1147
[8]   USE OF GRANULOCYTE-COLONY-STIMULATING FACTOR BEFORE, DURING, AND AFTER FLUDARABINE PLUS CYTARABINE INDUCTION THERAPY OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROMES - COMPARISON WITH FLUDARABINE PLUS CYTARABINE WITHOUT GRANULOCYTE-COLONY-STIMULATING FACTOR [J].
ESTEY, E ;
THALL, P ;
ANDREEFF, M ;
BERAN, M ;
KANTARJIAN, H ;
OBRIEN, S ;
ESCUDIER, S ;
ROBERTSON, LE ;
KOLLER, C ;
KORNBLAU, S ;
PIERCE, S ;
FREIREICH, E ;
DEISSEROTH, A ;
KEATING, M .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :671-678
[9]  
HIDDEMANN W, 1993, BLOOD S1, V82, P199
[10]   COMPARATIVE SAFETY, TOLERANCE, AND PHARMACOKINETICS OF AMPHOTERICIN-B LIPID COMPLEX AND AMPHOTERICIN-B DEOXYCHOLATE IN HEALTHY MALE-VOLUNTEERS [J].
KAN, VL ;
BENNETT, JE ;
AMANTEA, MA ;
SMOLSKIS, MC ;
MCMANUS, E ;
GRASELA, DM ;
SHERMAN, JW .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (02) :418-421